United States · FDA National Drug Code directory
medroxyprogesterone acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-5925_66ef6644-216f-4f03-af6e-d3ca132cf7cc
- Product NDC
- 50090-5925
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- medroxyprogesterone acetate
- Labeler
- A-S Medication Solutions
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20211021
- Source listing expiry
- 20261231
Source-listed ingredients
- MEDROXYPROGESTERONE ACETATE — 150 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (50090-5925-0) / 1 mL in 1 SYRINGE · 50090-5925-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →